Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirin Shafazand

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Evidence-Based Medicine|February 1, 2007
Review: long acting beta2 adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary diseaseShirin Shafazand
ACP Journal Club|January 6, 2007
Review: long-acting beta2-adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary diseaseShirin Shafazand
ACP Journal Club|January 6, 2007
Review: anticholinergics, but not beta2-agonists, reduce exacerbations requiring hospitalization and respiratory deaths in COPDShirin Shafazand
Annals of Internal Medicine|June 20, 2013
ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPDShirin Shafazand
Cleveland Clinic Journal of Medicine|November 3, 2009
Perioperative management of obstructive sleep apnea: ready for prime time?Shirin Shafazand
Seminars in Respiratory Infections|September 25, 2003
When bioterrorism strikes: diagnosis and management of inhalational anthraxShirin Shafazand
Evidence-Based Medicine|June 3, 2008
Review: corticosteroids plus LABAs reduce exacerbations and mortality more than steroids alone in COPDShirin Shafazand
Annals of Internal Medicine|May 16, 2017
Guideline: Insufficient evidence exists on screening for obstructive sleep apnea in asymptomatic adultsShirin Shafazand
Evidence-Based Medicine|February 1, 2007
Review: anticholinergics but not beta2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPDShirin Shafazand
Annals of Internal Medicine|April 21, 2015
ACP Journal Club: review: in patients with obstructive sleep apnea, continuous positive airway pressure increases weightShirin Shafazand
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Evidence-Based Medicine|February 1, 2007
Review: long acting beta2 adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary diseaseShirin Shafazand
ACP Journal Club|January 6, 2007
Review: long-acting beta2-adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary diseaseShirin Shafazand
ACP Journal Club|January 6, 2007
Review: anticholinergics, but not beta2-agonists, reduce exacerbations requiring hospitalization and respiratory deaths in COPDShirin Shafazand
Annals of Internal Medicine|June 20, 2013
ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPDShirin Shafazand
Cleveland Clinic Journal of Medicine|November 3, 2009
Perioperative management of obstructive sleep apnea: ready for prime time?Shirin Shafazand
Seminars in Respiratory Infections|September 25, 2003
When bioterrorism strikes: diagnosis and management of inhalational anthraxShirin Shafazand
Evidence-Based Medicine|June 3, 2008
Review: corticosteroids plus LABAs reduce exacerbations and mortality more than steroids alone in COPDShirin Shafazand
Annals of Internal Medicine|May 16, 2017
Guideline: Insufficient evidence exists on screening for obstructive sleep apnea in asymptomatic adultsShirin Shafazand
Evidence-Based Medicine|February 1, 2007
Review: anticholinergics but not beta2 agonists reduce exacerbations requiring hospital admission and respiratory deaths in COPDShirin Shafazand
Annals of Internal Medicine|April 21, 2015
ACP Journal Club: review: in patients with obstructive sleep apnea, continuous positive airway pressure increases weightShirin Shafazand
Pageof 6